tm
Seeing Is Believing
tm
Seeing Is Believing
CUE is currently covered by 4 analysts with an average price target of $7.92. This is a potential upside of $6.7 (549.18%) from yesterday's end of day stock price of $1.22.
Cue Biopharma's activity chart (see below) currently has 16 price targets and 21 ratings on display. The stock rating distribution of CUE is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 14.86% with an average time for these price targets to be met of 29.2 days.
Highest price target for CUE is $4, Lowest price target is $2, average price target is $7.92.
Most recent stock forecast was given by STEPHEN WILLEY from STIFEL on 20-Aug-2024. First documented stock forecast 24-Feb-2020.
Currently out of the existing stock ratings of CUE, 9 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$4
$2.98 (292.16%)
$8
3 months 9 days ago
(20-Aug-2024)
1/5 (20%)
$3.14 (365.12%)
12
Buy
$2
$0.98 (96.08%)
$15
4 months 3 days ago
(26-Jul-2024)
2/5 (40%)
$1.33 (198.51%)
60
Buy
$3
$1.98 (194.12%)
$8
4 months 3 days ago
(26-Jul-2024)
0/3 (0%)
$2.33 (347.76%)
Buy
$10
$8.98 (880.39%)
$10
1 years 5 months 3 days ago
(26-Jun-2023)
1/7 (14.29%)
$6.29 (169.54%)
74
Buy
$26
$23.89 (1132.23%)
$28
2 years 8 months 11 days ago
(18-Mar-2022)
0/2 (0%)
$20.42 (365.95%)
What is CUE (Cue Biopharma) average time for price targets to be met?
Which analyst has the current highest performing score on CUE (Cue Biopharma) with a proven track record?
Which analyst has the current lower performing score on CUE (Cue Biopharma) with a proven track record?
Which analyst has the most public recommendations on CUE (Cue Biopharma)?
Which analyst is the currently most bullish on CUE (Cue Biopharma)?
Which analyst is the currently most reserved on CUE (Cue Biopharma)?
